About EpiVario

About company

EpiVario is a preclinical pharmaceutical company that develops novel compounds for the goal of reducing or preventing the pathogenesis of psychiatric diseases: post-traumatic stress disorder (PTSD) and substance abuse disorders. EpiVario was founded in 2017 and is based in Philadelphia, Pennsylvania.